Both in Pharmaceuticals
Amneal Pharmaceuticals vs Alkermes
Over the past year AMRX returned +104.7% and ALKS returned +40.5%; their daily moves had a correlation of 0.27.
AMRX +104.7% ALKS +40.5%Growth of $1, one year, split-adjusted
| Metric | AMRX | ALKS |
|---|---|---|
| Price | $20.20 | $40.80 |
| Market cap | $7.04B | $6.84B |
| Today | −1.46% | +1.62% |
| 1 month | +15.2% | −13.9% |
| 6 months | +69.0% | +35.3% |
| Year to date | +60.3% | +45.8% |
| 1 year | +107.2% | +46.3% |
| Revenue growth (YoY) | +9.9% | +27.0% |
| Gross margin | 42.0% | 80.2% |
| Net margin | 7.2% | 0.1% |
| P/E (TTM) | 44.7× | 103.5× |
| Price / sales | 2.3× | 4.1× |
| Net cash | -$2.54B | -$846.5M |
| Dividend yield | — | — |
| Volatility (60d) | 40.0% | 30.5% |
| Short % of float | 6.1% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).